George Kunos and Pál Pacher are at the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20892-8115, USA. gkunos@mail.nih.gov or pacher@mail.nih.gov
Cannabinoids inhibit motility and secretion in the intestine. They are now assigned the additional task of curbing excessive inflammation, suggesting that drugs targeting the endogenous cannabinoid system could be exploited for inflammatory bowel disease.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
